Sensulin
PrivateLast Round
Series A
Dec 16, 2021
Total Funding Raised
$4.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sensulin is a biopharmaceutical company that is developing a glucose-responsive insulin for type 1 and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensulin Comparables
Compare Sensulin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermalin Diabetes | 81% | |
| Zenomics, Inc. | 76% | |
| Merck & Co., Inc. | 76% |
Sensulin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 16, 2021 | ||||
| VC Round | May 25, 2018 | ||||
| Grant | Dec 1, 2013 | ||||
| Seed | Feb 1, 2013 | ||||
| Grant | Sep 1, 2009 |
Sensulin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| StartUp Health | Series A |
| Cortado Ventures | Series A |
| National Science Foundation | Grant |
| AngelMD | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Monthly visitors grew 121% MoM, reaching 3.3K.
- Apr 18, 2026
Monthly visitors grew 68% MoM, reaching 5.4K.
Sensulin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sensulin's valuation, stock price, and market status.
Is Sensulin a public or private company?
Sensulin is a private company.
What is the current stock price of Sensulin?
Sensulin is a private company with no public stock price. No recent secondary market data is available.
How much is Sensulin worth (valuation)?
Valuation information for Sensulin is not publicly available.
Can I buy Sensulin stock?
Sensulin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sensulin's last funding round?
Sensulin's most recent funding round was Series A on December 16, 2021.
Who are the main investors in Sensulin?
Key investors in Sensulin include National Institute of Diabetes and Digestive and Kidney Diseases, StartUp Health, Cortado Ventures, National Science Foundation, angelMD.
Will Sensulin IPO soon?
No public IPO plans have been announced for Sensulin.
How can I track Sensulin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sensulin's secondary market activity and sign up for updates.